Screener
Alnylam Pharmaceuticals ALNY Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's operating margin?
- Alnylam Pharmaceuticals (ALNY) reported operating margin of 20.8% in Q2 2026.
- How has Alnylam Pharmaceuticals's operating margin changed year-over-year?
- Alnylam Pharmaceuticals's operating margin increased by 384.3% year-over-year, from -7.3% to 20.8%.
- What is the long-term trend for Alnylam Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's operating margin has grown at a -39.6% compound annual growth rate (CAGR), from -168.1% to 13.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Alnylam Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude